Skip banner links and go to contentU.S. Department of Health & Human Services * National Institutes of Health
National Heart, Lung, and Blood Institute:  Diseases and Conditions Index
Tell us what you think about this site
  Enter keywords to search this site. (Click here for Search Tips)  
U.S. Department of Health & Human Services National Institutes of Health Diseases and Conditions Index NIH Home NHLBI Home About This Site NHLBI Home NHLBI Home Link to Spanish DCI Tell us what you think
 DCI Home: Lung Diseases: LAM: Printer Friendly Summary Page

  Lymphangioleiomyomatosis

What Is LAM?

LAM, or lymphangioleiomyomatosis (lim-FAN-je-o-LI-o-MI-o-ma-TO-sis), is a rare lung disease that mostly affects women in their mid-forties.

In LAM, an unusual type of cell begins to grow out of control throughout your body, including in the lungs, lymph nodes and vessels, and kidneys.

Over time, these LAM cells form cysts and clusters of cells, which grow throughout the lungs and slowly block the airways. They also destroy the normal lung tissue and replace it with cysts. As a result, air cannot move freely in and out of the lungs, and the lungs cannot supply enough oxygen to the body’s other organs.

More than 1 out of every 3 people with LAM also develops growths called angiomyolipomas (AN-je-o-my-o-li-PO-mas), or AMLs, in their kidneys. People with LAM also may develop:

  • Growths in other organs, including the liver and brain
  • Large tumors on their lymph nodes

There currently is no cure for LAM.

The most common cause of death from LAM is respiratory failure.

There are two forms of LAM:

  • Sporadic LAM, which occurs for unknown reasons
  • An often milder form of LAM that occurs in people with a rare inherited disease called tuberous sclerosis complex

The term “lymphangioleiomyomatosis” comes from the Greek. “Lymph” and “angio” refer to the lymph vessels, and “leiomyomas” refers to the type of cells involved in LAM.

Doctors have learned a lot about LAM in recent years. They are now able to diagnose the condition earlier and provide support services that improve patients’ quality of life. Not too long ago, doctors thought that the life expectancy for women with LAM was less than 10 years following diagnosis. We now know that some patients with LAM may survive for more than 20 years.


What Causes LAM?

Researchers do not know what causes LAM, or why it affects mostly women. They have recently discovered that LAM has some of the same features as another rare disease called tuberous sclerosis complex (TSC). This discovery has begun to provide some valuable clues about what causes LAM.

The common features of LAM and TSC are:

  • People with TSC develop growths in their kidneys that are the same as the angiomyolipomas that many people with LAM develop in their kidneys.
  • About 1 out of every 3 women who has TSC develops cysts in her lungs that are the same as the ones women with LAM develop in their lungs.

TSC is a genetic disease. It is caused by abnormalities, or defects, in one of two genes. These genes are called TSC1 and TSC2. Normally, they make proteins that control the growth of the cells in the body. In people with TSC, the genes are abnormal, and the proteins that they make cannot control cell growth and movement.

LAM patients also have abnormal versions of the TSC1 and TSC2 genes, and researchers have discovered that these genes play a role in the development of LAM. More research on the TSC genes and the proteins that they make should shed new light on the causes of LAM.

Since LAM mostly affects women in their mid-forties, many doctors think that estrogen also plays a role in causing LAM.


Who Is At Risk for LAM?

LAM mostly affects women in their mid-forties. More than 7 out of every 10 patients are between the ages of 20 and 40 when they begin to have symptoms. But LAM may occur in women as old as 70 to 80. There are also a few reports of LAM occurring in men.

Today, about 675 women in the United States have been diagnosed with either LAM alone or LAM with tuberous sclerosis complex. Scientists believe that many more women have LAM, but they have been misdiagnosed with another more common lung disease, such as emphysema, asthma, or bronchitis.

Since LAM affects about 3 out of every 10 women with TSC, there may be as many as 10,000 women in the United States who have TSC and undiagnosed LAM. Many of these women may have mild cases of LAM that are not causing symptoms. Not all TSC patients who have LAM have lung problems.


What Are the Signs and Symptoms of LAM?

The signs and symptoms of LAM are caused by the uncontrolled growth of the LAM cells.

The most common signs and symptoms are:

  • Shortness of breath, especially following exertion. At first, you may feel short of breath only during strenuous activity. Over time, you may have trouble breathing even during rest.
  • Chest pain, usually caused by a collapsed lung.
  • Frequent cough, sometimes with bloody phlegm.

LAM also can lead to other serious conditions:

  • About 6 of every 7 women with LAM develop a collapsed lung (pneumothorax (noo-mo-THOR-aks)) at some point. Sometimes one lung will collapse over and over again. Both lungs can collapse too. This is a serious condition that can be life threatening. A lung that is only partly collapsed may slowly re-expand without treatment, but treatment is often required.
  • In 1 out of every 3 women with LAM, a fluid called lymph leaks into the chest cavity and builds up.
  • Nearly half of the women with LAM develop growths called angiomyolipomas in their kidneys.

Many women with LAM also have:

  • Blood or lymph in their sputum
  • Blood in their urine
  • Enlarged lymph nodes
  • Abdominal swelling

Other diseases can cause many of these signs and symptoms and complications, so it is important that you see a doctor.


How Is LAM Diagnosed?

Methods for diagnosing LAM have improved, and it is now possible to diagnose it at an early stage.

Many of the signs and symptoms of LAM can be caused by other diseases such as asthma, emphysema, and bronchitis. It is important for your doctor to rule out those conditions before making a final diagnosis.

  • Chest x ray. A chest x ray takes a picture of your heart and lungs. It can show a collapsed lung or fluid in your chest cavity. In the early stages of LAM, your chest x rays may look normal, but as the disease gets worse, they may show cysts in your lungs.
  • Lung function tests. For these tests, you breathe through a mouthpiece into a machine called a spirometer (spi-ROM-e-ter). The spirometer measures the amount of air you inhale and exhale and how fast your lungs move it in and out. These tests also can provide an estimate of the amount of air your lungs can hold, and how well your lungs can take oxygen into the bloodstream.
  • Exercise stress test. This test helps the doctor evaluate the effect of exercise on your heart and lungs.
  • Blood tests. The doctor takes a sample of your blood from an artery in your arm and examines it to see whether your lungs are providing enough oxygen to your blood. These tests may show low oxygen levels in your blood even when you are resting. The doctor also may take a blood sample from a vein in your arm to look at your blood cells and blood chemistry.
  • Pulse oximetry. A small sensor attached to your fingertip also can give an estimate of the level of oxygen in your blood.
  • High-resolution CT scan (HRCT). This test shows a computer-generated picture of your lungs that has more detail than a chest x ray. It is the most useful imaging test for diagnosing LAM. HRCT can show cysts or shadows of cell clusters in your lungs, a collapsed lung, or enlarged lymph nodes. It also can show how much normal lung tissue has been replaced by the LAM cysts. HRCT scans of your abdomen and pelvis can show if you have growths in your kidneys, other abdominal organs, or lymph nodes.
  • Lung biopsy. Although the tests mentioned above sometimes provide enough information for your doctor to diagnose LAM, the most useful test involves removing samples of your lung tissue so they can be looked at under a microscope. You should go to a doctor who specializes in LAM for this test. Several procedures can be used to obtain lung tissue:
    • Thoracoscopy (tho-rah-KOS-ko-pe). Your doctor inserts a small, lighted tube (endoscope) into little incisions in your chest wall. This lets him or her see the insides of your chest and snip out a few small pieces of lung tissue. This procedure is done in a hospital, and you are under general anesthesia. It is not major surgery, but it usually provides all the tissue your doctor needs.
    • Open lung biopsy. Your doctor removes a few small pieces of lung tissue through an incision in your chest wall between your ribs. This procedure also is done in the hospital, and you are under general anesthesia. Recovery takes longer than recovery from thoracoscopy.
    • Transbronchial biopsy. Your doctor inserts a long, narrow, flexible, lighted tube (bronchoscope) down your windpipe, or trachea (TRA-ke-ah), into your lungs. He or she then snips out bits of lung tissue with a tiny forceps. This procedure is usually done in a hospital on an outpatient basis, and you are under local anesthesia. Doctors usually are not able to remove enough tissue to diagnose LAM with this procedure.

Some doctors recommend that once you are diagnosed with LAM, you have magnetic resonance imaging (MRI) of your head. This test can show if you have signs of tuberous sclerosis complex (TSC) or a growth in your brain called a meningioma (me-NIN-je-O-mah). About 1 out of every 20 patients with LAM has this kind of growth. It also appears in people with TSC.

The National Institutes of Health is studying whether blood tests for the TSC1 and TSC2 genes may be helpful in diagnosing LAM patients.


How Is LAM Treated?

There is no treatment available yet to slow or stop the growth of the cell clusters and cysts that are the major feature of LAM.

Most treatments for LAM are aimed at relieving symptoms and preventing complications.

Since many women with LAM are now living so much longer, doctors also focus on treating other health problems that happen with menopause and aging.

The main treatments for LAM are:

  • Medicines
  • Oxygen therapy
  • Procedures to remove fluid from the chest or abdominal cavities and prevent it from building up again
  • Procedures to remove angiomyolipomas (AMLs)
  • Lung transplantation

Medicines

Some medicines may help open your lungs so that you can breathe more easily.

  • Bronchodilators are drugs that relax the muscles around the airways. As a result, the airways can open up, making it easier to breathe. About 1 out of 5 women with LAM improves with the use of bronchodilators.
  • Octreotide and diuretics are sometimes used to prevent the buildup of fluid in the chest cavity and abdomen. Octreotide may reduce leakage of lymph into the abdominal or chest cavity.

Women with LAM have a greater chance of developing osteoporosis (a condition that causes bones to become weak and brittle) than other women. If you have LAM, your doctor should measure your bone density. If you have lost bone density, your doctor may prescribe drugs that prevent bone loss. He or she also may prescribe calcium and vitamin D supplements.

Physicians who think that estrogen may play a role in the development of LAM usually treat their patients with hormone therapy.

Oxygen Therapy

If the level of oxygen in your blood is low, you may need oxygen therapy. Oxygen is usually given through nasal prongs or a mask. At first, you may need oxygen only while exercising. It also may help to use it while you are sleeping. Over time, you may need full-time oxygen therapy.

Your doctor may give you a standard exercise stress test or a 6-minute walk test to find out whether you need oxygen while exercising. A blood test will show what your oxygen level is and how much oxygen you need.

Procedures To Remove Air or Fluid From the Chest or Abdomen

Several procedures help remove air or fluid from your chest and abdominal cavities and prevent them from building up in your chest cavity.

  • Removing fluid from your chest or abdominal cavities may help relieve abdominal discomfort and shortness of breath. Your doctor can usually remove this fluid with a needle and syringe. If large amounts of fluid build up in your chest cavity, your doctor may have to insert a tube into your chest to remove it.
  • Removing air from your chest cavity may relieve shortness of breath and chest pain caused by a collapsed lung. Your doctor can usually remove the air with a tube that is inserted into your chest cavity between your side ribs. The tube is usually attached to a suction device. If this procedure doesn't work, or if your lungs collapse frequently, you may need surgery.
  • If lymph and air leak into your chest cavity often, your doctor may perform a procedure to fuse your lung and chest wall together and remove space for leakage. This procedure is called pleurodesis (ploo-ROD-e-sis). It involves injecting a chemical into the place where the leakage is happening. Your doctor may do it at your bedside, while you are under local anesthesia. It also can be done in the operating room by video-assisted thoracoscopy surgery, while you are under general anesthesia.

Procedures To Remove AMLs

If you have ongoing severe pain or bleeding caused by AMLs, surgery to remove some of the abdominal growths may be helpful. If the bleeding is not too severe, an experienced radiologist can often block the blood vessels feeding the AMLs. This may cause them to shrink.

Lung Transplantation

Surgery to replace one or both of your lungs with healthy lungs from a human donor may be helpful. Survival after a lung transplant for LAM is probably better than survival after a lung transplant for another condition, such as emphysema.

Lung transplantation has a high risk of complications.

In a few cases, doctors have found LAM cells in the new transplanted lungs and other parts of the body, but the LAM cells do not seem to prevent the transplanted lung from working.

Possible New Treatments for LAM

Researchers are now studying several medicines as possible treatments for LAM, including rapamycin.

Rapamycin (sirolimus) is the first drug to show promise as a treatment that will slow or stop the development and growth of the LAM cell clusters. Doctors now use it to prevent the immune system from rejecting kidney transplants. Researchers are looking into whether this medicine can reduce the size of kidney AMLs in LAM and tuberous sclerosis complex (TSC) patients. They also are planning a larger study of the effects of rapamycin, or another drug like it, on TSC and LAM patients. This study will test whether the drug can prevent or reverse the growth of the LAM cell clusters and cysts in other organs and slow the decline of lung function.


Living With LAM

In the early stages of LAM, you usually can go about your daily activities, including attending school, going to work, and performing common physical activities such as walking up a hill. Later on, it may be harder for you to be active. You also may require oxygen full time.

Ongoing medical care is important. Treatment by a pulmonologist who specializes in LAM is recommended. These specialists are usually located at major medical centers.

It is important for you to take good care of your health. This means following the same healthy lifestyle that is recommended for all Americans, including eating a healthy diet, being as physically active as you can, and getting plenty of rest. You also should not smoke.

You should check with your doctor before traveling by air or traveling to remote areas where medical attention is not readily available. You also should ask about travel to places where the amount of oxygen in the air is low.

If your lung function is normal, pregnancy may be an option, but you should discuss it first with both a pulmonologist who specializes in LAM and your obstetrician.

Most doctors do not recommend oral contraceptives (birth control pills) containing estrogen. You also should avoid estrogen-rich foods. Progesterone may be used as a contraceptive.

Joining a LAM support group can be helpful. Information about patient support groups is available from the National Institutes of Health/National Heart, Lung, and Blood Institute Pulmonary-Critical Care Branch at 1–877–NIH–LUNG (1–877–644–5864), extension 3.


Key Points

  • LAM is a rare lung disease that mostly affects women in their mid-forties. It is sometimes seen in older women as well. It almost never affects men.
  • In LAM, clumps of cells and cysts grow throughout the lungs. Over time, they destroy the normal lung tissue and block the flow of air. They also reduce oxygen intake by the lungs.
  • More than 1 out of every 3 women with LAM develops growths called angiomyolipomas (AMLs) in their kidneys.
  • There are two forms of LAM: sporadic LAM, in which the disease comes on for unknown reasons, and LAM that appears in people with a rare inherited disease called tuberous sclerosis complex (TSC).
  • Doctors do not yet know what causes LAM. The recent discovery of similarities between LAM and TSC has begun to provide some valuable clues about the genes involved in both conditions.
  • The symptoms of LAM include shortness of breath (especially following periods of exertion), chest pain, and a frequent cough, sometimes with bloody phlegm.
  • LAM can lead to other serious conditions, including a collapsed lung, blood in the urine, and abdominal swelling.
  • To confirm or rule out LAM, doctors usually do a chest x ray, lung function tests, blood tests, pulse oximetry, high resolution CT scans, and lung biopsy.
  • Doctors have not yet found any treatments to slow or stop the growth of the cell clusters or cysts that are the main features of LAM. As a result, most treatments are aimed at relieving symptoms and preventing complications. These treatments include inhaled bronchodilators, oxygen therapy, removal of air or fluid from your chest or abdominal cavities, and lung transplantation.
  • Several medicines are now being investigated as possible treatments for LAM, including rapamycin.
  • Most people with LAM can usually continue to be active in the early stages of the disease. If the condition becomes worse, they may not be able to be active, and they may need oxygen full time.

Links to Other Information About LAM

NHLBI Resources

Non-NHLBI Resources

Clinical Trials


Skip bottom navigation and go back to top
Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute
Blood Diseases | Heart and Blood Vessel Diseases | Lung Diseases | Sleep Disorders
NHLBI Privacy Statement | NHLBI Accessibility Policy
NIH Home | NHLBI Home | DCI Home | About DCI | Search
About NHLBI | Contact NHLBI

Note to users of screen readers and other assistive technologies: please report your problems here.